Correction on PTC Therapeutics and PTC299
I have a correction on the Phase 2 clinical trials offered by PTC Therapeutics. Originally, I linked their PTC299 with bevacizumab because the news releases came out near each other and the descriptions of the drugs and their effects sounded similar.
PTC299 is not bevacizumab. I have corrected the original entry.